]EpI partly inhibited acetylcholine-evoked currents in isolated parasympathetic neurons of rat intracardiac ganglia. These results indicate that EpI and [Tyr

15
]EpI selectively inhibit ␣3␤2 and ␣3␤4 nicotinic acetylcholine receptors.
Cone snail venoms contain complex mixtures of peptides (conotoxins or conopeptides) that bind with high affinity and specificity to a diversity of mammalian macromolecular receptors. Targets currently identified include sodium, calcium, and potassium ion channels and N-methyl-D-aspartate-glutamate, vasopressin and acetylcholine receptors. Most characterized bioactive conopeptides contain post-translational modifications that include carboxylation, hydroxylation, bromination, and C-terminal amidation (1-3) but modifications such as phosphorylation or sulfation have not been demonstrated.
One pharmacological class of conopeptides, the ␣-conotoxins, inhibit acetylcholine action at the nicotinic acetylcholine receptor (nAChR). 1 The majority of ␣-conotoxins isolated from fishhunting cone snails, including GI, GIA, and GII from Conus geographus (4) , MI from Conus magus (5) , and SI and SII from Conus striatus (6, 7) , show extensive structural homology, a conserved cysteine framework, and target the muscle subtype of the nAChR. The ␣-conotoxins PnIA and PnIB from a molluschunting cone snail, Conus pennaceus (8) , and ImI from a wormhunting cone snail, Conus imperialis (9) share a similar cysteine framework to ␣-conotoxins from fish-hunting cones, but have a different sequence pattern and target the neuronal subtypes of the nAChR. The ␣-conotoxins MII and EI from fish-hunting cones resemble the latter group in sequence pattern, but EI targets the muscle-type nAChR (10, 11) . The new ␣A-conotoxin class, which includes PIVA isolated from the fishhunting Conus purpurascens, contains atypical sequences and a novel cysteine framework (12) . The sequence, disulfide connectivity, and specificity of ␣-conotoxins for mammalian nAChRs are given in Table I .
The nAChRs are a superfamily of ligand-gated ion channels that is classified into muscle and multiple neuronal subtypes (13) . The physiological and pharmacological heterogeneity of neuronal nAChRs is reflected by the diversity of subunit composition of these heteropentameric ion channel complexes (14, 15) . Neuronal receptors are composed of several possible ␣ subtypes (␣2-␣7, ␣9) and 3 possible ␤ subtypes (␤2-␤4), whereas muscle receptors are composed of five subunits ␣1 2 ␤⑀␦ or ␣1 2 ␤␥␦ in mature or embryonic tissue, respectively (13) . Neuronal nAChRs are distributed in numerous brain regions and on both cell soma and dendrites, but it is the action of nAChRs to modulate synaptic transmission presynaptically that has received much attention recently (14, 16, 17) . Selective activation of distinct subtypes of these presynaptic nAChRs by nicotinic agonists can regulate the release of different neurotransmitters, including dopamine, norepinephrine, glutamate, GABA, and acetylcholine (14) . To gain a better insight into the role of the various nAChR subtypes in neurotransmission, additional selective nAChR antagonists are required.
In this report we describe EpI, a novel conotoxin from the molluscivorous C. episcopatus that targets the nAChR. The peptide has the cysteine framework typical of ␣-conotoxins and substantial sequence homology with the other ␣-conotoxins isolated from non-piscivorous Conus species (see Table I ). However, EpI differs from all previously reported ␣-conotoxins in that it possesses a sulfotyrosine residue.
MATERIALS AND METHODS
Isolation of EpI from Conus episcopatus
Five specimens of C. episcopatus (Fig. 1) were collected from The Great Barrier Reef, Australia, dissected and an extract of crude venom prepared from the pooled venom duct material as described previously (18) . Briefly, ground dried ducts were extracted with 30% acetonitrile/ water acidified with 0.1% trifluoroacetic acid, centrifuged, and the supernatants lyophilized (yield 84 mg) and stored at Ϫ20°C prior to HPLC separation.
Isolation and Purification of EpI
Crude venom (4.4 mg) was fractionated by preparative reversedphase HPLC (Waters) using a 10-m Vydac C18 column (1.0 ϫ 25 cm) eluted at 2.5 ml/min with a linear gradient from 0 to 80% B over 80 min: solvent A, 10% acetonitrile, 0.1% trifluoroacetic acid; solvent B, 90% acetonitrile, 0.09% trifluoroacetic acid. Absorbance was monitored at 214 and 280 nm. A major peak eluting at ϳ20 min was further purified by analytical reversed-phase HPLC using a 5-m Vydac C18 column (0.46 ϫ 25 cm) eluted at 1 ml/min with a linear gradient of 0 to 50% B over 45 and 90 min. Absorbance was monitored at 214 nm.
Primary Structure of EpI
A sample of approximately 100 pmol of purified native peptide was fully reduced in the presence of 50 mM dithiothreitol and 50 mM ammonium acetate, pH 8.5, at 37°C for 1 h, then alkylated in the presence of 100 mM 4-vinylpyridine for 1 h at room temperature in the dark. The alkylated peptide was repurified by HPLC and analyzed by Edman chemistry on an ABI model 470A protein sequencer.
Sulfotyrosine Analysis of EpI
Enzymatic Treatment-A hydrolysate of EpI was prepared by carboxypeptidase Y digestion. Briefly, a sample of ϳ2 nmol of native EpI was dissolved in 100 l of 50 mM ammonium acetate, pH 5.5, and treated with 0.75 g of carboxypeptidase Y (Boehringer Mannheim, sequencing grade) for 24 h at room temperature (enzyme to protein ratio ϳ 1:5). The products of the enzymatic degradation were assessed by analytical C18 HPLC, mass spectrometry (MS), and amino acid analysis.
Preparation of Sulfated Tyrosine Standard-Sulfated Fmoc-Tyr was treated overnight in mild sodium hydroxide. The reaction mixture was purified on a 5 M Vydac C 18 reversed-phase column (0.46 ϫ 25 cm). With a standard gradient of 0.1% trifluoroacetic acid/acetonitrile, sulfated tyrosine eluted cleanly in the solvent front, while the remaining reaction products were retained on a C 18 column. Purity of the sulfated tyrosine (262 Da) was confirmed by MS.
Derivatization of Amino Acids with PITC and Analysis by HPLCThe free amino acids liberated from the digested peptide and amino acid standards were derivatized with PITC (19) . The digests and standards were redried after addition of 40 l of ethanol/water/triethylamine (2:2:1). The derivatization reagent consisted of ethanol/triethylamine/ water/PITC (7:1:1:1) which was made fresh daily. The dried samples were resolubilized with 40 l of derivatization reagent and the sealed samples allowed to react for 30 min before drying under vacuum. Derivatized amino acids were separated on a Pico-Tag column (Waters) using a linear gradient from 0% B to 46% B over 18 min: solvent A, 0.14 M sodium acetate containing 0.05% (v/v) triethylamine and adjusted to pH 6.35 with glacial acetic acid; solvent B, 60% acetonitrile/water.
Mass Spectrometry (MS)
Mass spectra were acquired on a PE-SCIEX API 111 triple quadrupole mass spectrometer (PE-SCIEX, Ontario, Canada) equipped with an ion spray atmospheric pressure ionization source. Samples (20 l) were injected into a moving solvent (10 l/min; 50% acetonitrile, 0.05% trifluoroacetic acid) coupled directly to the ionization source via a fused silica capillary interface (50 m ϫ 50 cm). Sample droplets were analyzed in both the positive and negative ionization modes. The ions entered the analyzer through an interface plate and subsequently through an orifice (100 -120 m diameter) at declustering potentials from 10 to 90 V in the positive ion mode, and at -50 V in the negative ion mode. Full scan spectra were acquired over m/z 500 -2200 in 0.2 Da steps with a total scan time of 3 s.
To help determine if EpI was sulfated, MS spectra of native and synthetic EpI, CCK-8 (a sulfated peptide standard) and MLP111 (a phosphorylated peptide standard) were acquired over m/z 50 -100. A high declustering voltage of -220 V and negative ion detection were used to confirm the presence of the sulfate and related ions. The declustering potential is the orifice voltage less the reference voltage (R0), which was 30 or -30 V in positive or negative ion modes, respectively.
HPLC/MS analysis of crude venom (20 l of a 2 mg/ml solution) was performed with a 5-m Vydac C 18 column (0.21 ϫ 25 cm) eluted at 130 l/min with 100% A for 2 min and then 0 to 80% B over 80 min: solvent A, 0.05% trifluoroacetic acid; solvent B, 90% acetonitrile, 0.05% trifluoroacetic acid. Mass spectra were acquired over m/z 400 -2200 at 0.2 Da steps, with a dwell time of 0.3 ms and a total scan time of 3.2 s.
Determination of Disulfide Connectivity
Native EpI (1 nM) was added to the reaction buffer (25 l; 0.1 M NH 4 OAc/acetonitrile, 90/10 (v/v); pH 4) and reacted with the reducing agent Tris(2-carboxyethyl)phosphine (2:1, w/w). An aliquot (1 l) was injected into the MS to determine the extent of reduction over 2 to 10 min. This partially reduced EpI was reacted with 100 mM of the alkylating reagent maleimide (pH 4.0; 21°C) over 5 min with 1-l aliquots injected into the MS to determine the extent of alkylation. A reaction product representing the alkylation of one disulfide bond, as determined by MS, was isolated using reversed-phase gradient HPLC on a 5-m Vydac C18 column (0.21 ϫ 25 cm). To determine disulfide bond connectivity of EpI, this partially reduced product was subjected to Edman sequencing. Disulfide bond connectivity was also determined by collision-induced dissociation MS. Collision-induced dissociation of the partially reduced and alkylated parent precursor ion was effected by bombardment with ultrapure Argon. Bombardment was carried out in quadrupole-2 with a collision cell gas thickness of 3 ϫ 10 14 atoms/cm 2 and a collision energy (Q-0 to Q-2 rod offset voltage) of typically 20 -40 eV relative to the laboratory frame. The resulting product ion spectra were obtained by scanning quadrupole-3 over m/z 50 -2200 at 0.2 Da steps. Spectra were analyzed with MacBioSpec (PE-SCIEX).
Peptide Synthesis
Chain Assembly-Two peptides, EpI and [Tyr 15 ]EpI, were each synthesized on a 0.5-mmol scale by manual solid phase peptide synthesis using Fmoc chemistry. The following amino acid side chain protecting groups were used: Arg(Pmc), Asn(Trt), Asp(OtBu), Cys(Trt), and Ser(tBu). Met, Gly, and Pro, were used without side chain protection. Sulfated tyrosine was used for the synthesis of EpI and Tyr(tBu) was used for the synthesis of the unsulfated peptide ([Tyr 15 ]EpI). Peptide resin samples (ϳ5 mg) were removed after each coupling step for determination of residual free ␣-amino groups by the quantitative ninhydrin test (20) , except for couplings to proline where a coupling efficiency of Ͼ99.5% was assumed where the result of a modification of the Isatin test (21, 22) was satisfactory. Double couplings were used to achieve coupling efficiencies of Ͼ99.5%. First couplings Ͻ95% were obtained only for residues 8 and 9 of [Tyr 15 ]EpI. Deprotection, Cleavage, and Peptide Oxidation-The N ␣ -Fmoc group was removed on resin from the fully protected peptide by treatment with piperidine/dimethylformamide (1:1, 2 ϫ 1 min) and the partially deprotected peptide resin was dried under a stream of nitrogen after washing with dimethylformamide and dichloromethane. The peptide was cleaved from the resin and the side chain protecting groups were simultaneously removed by treatment with (i) trifluoroacetic acid/H 2 O (9:1, v/v) with 50 eq of m-cresol or (ii) trifluoroacetic acid/triisopropylsilane (9:1, v/v) (33) , both at 4°C for 3 to 5 h with similar results. The majority of the trifluoroacetic acid was removed on a rotavapor and the crude peptide precipitated, washed with ether, dissolved in 50% acetonitrile, 0.1% trifluoroacetic acid, diluted with water, and lyophilized. The peptide precipitation, washing, and dissolution steps were carried out under a stream of nitrogen to minimize uncontrolled air oxidation of the peptide. The peptides were purified by reversed-phase HPLC and the purified reduced peptides (100 M) were oxidized in 100 mM NH 4 15 ]EpI were obtained using a preparative 10-m Vydac C18 column (2.2 ϫ 25 cm) eluted at 8 ml/min with 5 to 50% B over 60 min and 50 to 80% B over 20 min: solvent A, 0.1% trifluoroacetic acid; solvent B, 90% acetonitrile, 0.09% trifluoroacetic acid. The eluant was monitored at 230 nm. Retention times of native and synthetic peptides were compared by analytical reversed-phase HPLC (see above) eluted at 1 ml/min with a linear gradient of 0.7% acetonitrile/min from 0.1% trifluoroacetic acid to 90% acetonitrile, 0.09% trifluoroacetic acid. Coelution was confirmed by co-injection of synthetic and native EpI in a 2:1 ratio.
Materials for Peptide Characterization and Synthesis
Acetonitrile, ethanol, and glacial acetic acid were from BDH Laboratory Supplies, Poole, United Kingdom. High purity water was generated by a Milli-Q TM purification system (Millipore, Bedford, MA). Triethylamine (freshly distilled) was from Sigma. Phenylisothiocyanate (PITC) and amino acid standards were from Pierce. Sodium acetate was from Aldrich Chemical Co. 2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate, piperidine, trifluoroacetic acid, diisopropylethylamine, dimethylformamide (peptide synthesis grade), and Fmoc-sulfotyrosine were purchased from Auspep (Melbourne, Australia). Acetonitrile (HPLC grade) was obtained from Waters Millipore (Milford, MA). Fmoc-aa-resin (Ramage Amide-Resin, tricyclic amide linker) was purchased from BAChem and Fmoc-L-amino acids were purchased from BAChem, Nova Biochem, and Auspep. Stock solutions (100 mM) of Tris (2- 
Measurement of Catecholamine Secretion from Chromaffin Cells
Chromaffin cells were isolated from bovine adrenal medullary tissue and cultured as described previously (23) . The protocol employed for the catecholamine release studies was that detailed by Livett et al. (24) . Experiments were conducted on 24-well culture plates containing 0.4 ml of medium/well at 1.25 ϫ 10 6 cells/ml. Following a 3-day incubation at 37°C in an atmosphere of 10% carbon dioxide, the culture was allowed to equilibrate to room temperature for 5 min. To remove the incubation medium, the culture was washed with modified Locke's buffer of the following composition in mM: NaCl, 154; KCl, 2.6; CaCl 2 10 ; and bovine serum albumin, 0.5%. The cells were preincubated in the presence or absence of synthetic conotoxin (0 -10 M) for 5 min at room temperature and then incubated for 5 min with 4 M nicotine Ϯ conotoxin. Cells treated with buffer alone, 4 M nicotine alone, or conotoxin alone served as controls. The incubation medium containing released catecholamines was removed and acidified with 2 M perchloric acid. To determine total cell catecholamines, the cells in each culture plate well were treated for 5 min with 0.01 M perchloric acid to lyse the cells and acidified to a final concentration of 0.4 M perchloric acid. The released catecholamines were quantified by electrochemical oxidation, after separation by reverse-phase HPLC (24) . For K ϩ -induced catecholamine release experiments, 56 mM KCl was used as the agonist instead of nicotine. In the nicotine/conotoxin competition experiments, the cells were incubated with synthetic EpI or [Tyr 15 ]EpI at 1 M and varying concentrations of nicotine (0 -100 M).
Rat Phrenic Nerve-Hemidiaphragm Studies
Male Buffalo rats (150 -250 g, 3-4 months old) were sacrificed by asphyxiation with carbon dioxide and exsanguinated. The left hemidiaphragm and phrenic nerve were isolated as described previously (25) and mounted under 1 g of resting tension in a 25-ml organ bath containing Krebs-Henseleit solution aerated with carbogen (95% O 2 , 5% CO 2 ). The nerve was stimulated via a bipolar electrode with pulses of 0.5-ms duration and supramaximal voltage using a Grass S48 stimulator with an SIU5 isolation unit. Single twitches were produced by continuous stimulation at 0.1 Hz, interspersed at 5-min intervals by train-of-four twitches (2 Hz for 1.9 s) or tetanic contractions (50 Hz for 2 s), measured alternately. Responses were detected using a Grass FT03 isometric force-displacement transducer connected to a Neotrace DC amplifier and recorded via a Mac Lab/4S using the application Chart (v 3.4/s) on a Macintosh LC630 computer. The tissue was treated with synthetic conotoxin (1-10 M) in buffer for 60 min, washed several times with buffer alone, and then allowed a 30-min recovery time prior to treatment with the next higher toxin concentration. Data analyses were performed as described previously (26) .
Acetylcholine-evoked Currents in Rat Parasympathetic Neurons
Preparation-Membrane currents were studied in isolated parasympathetic neurons of neonatal rat intracardiac ganglia. The procedures for isolation of these neurons have been described in detail previously (27) . Briefly, neonatal rats (3-8 days old) were sacrificed by decapitation, and the heart was excised and placed in a saline solution containing (mM): 140 NaCl, 3 KCl, 2.5 CaCl 2 , 0.6 MgCl 2 , 7.7 glucose, and 10 HEPES (pH adjusted to 7.2 with NaOH). Atria were removed and incubated for 1 h at 37°C in saline solution containing 1 mg/ml collagenase (Type 2; Worthington Biochemical Corp., Freehold, NJ). Following enzymatic treatment, clusters of ganglia were dissected from the epicardial ganglion plexus, transferred to a sterile culture dish containing high glucose culture medium (Dulbecco's modified Eagle's medium), 10% (v/v) fetal calf serum, 100 units/ml penicillin, and 0.1 mg/ml streptomycin, and triturated using a fine-bore Pasteur pipette. The dissociated neurons were then plated onto 18-mm glass coverslips coated with laminin, and incubated at 37°C for 24 -72 h under 95% air, 5% CO 2 , in a humid atmosphere. At the time of the experiments, neurons were transferred to a recording chamber (0.5-ml volume) and viewed at 400 ϫ magnification using an inverted phase-contrast microscope.
Electrical Recordings and Data Analysis-Membrane currents were recorded from isolated intracardiac neurons under voltage clamp conditions using the whole-cell patch recording configuration (28) . In whole-cell experiments, electrical access was achieved either by rupturing the membrane patch and dialyzing the cell, or through the use of the perforated patch method (29) . The perforated patch method allows the intracellular integrity of the neurons to be maintained to confirm that any effects are independent of possible cell dialysis effects which can alter the functional response of these neurons (30) .
For perforated patch experiments, a stock solution of 60 mg/ml amphotericin B in dimethyl sulfoxide was prepared the day of the experiment and kept on ice, in the dark. Immediately prior to use, the amphotericin B stock solution was diluted in pipette solution (see below) to yield a final concentration of 360 g/ml amphotericin B in 0.6% dimethyl sulfoxide. Following gigaseal formation, the neurons were held at -70 mV and voltage pulses (20 ms) to -80 mV were applied at 1 Hz. Amphotericin B incorporation into the membrane patch resulted in a fast capacitive transient, the appearance of a slow capacitive transient and a decrease in the series resistance (R S ). Experiments were continued only if R S decreased to Յ10 megohm within 10 min of seal formation. Final series resistance was usually 5-8 megohm, and approximately 50% R S compensation was used.
Electrodes for whole-cell experiments were pulled from thin-walled borosilicate glass (TF150; Clark Electromedical Inst., Reading, United Kingdom) and the final pipette resistance was 1-3 megohm for conventional and perforated patch whole-cell recording. Membrane currents evoked by agonist application were amplified and filtered (5 kHz) using and Axopatch 200A patch clamp amplifier (Axon Instruments Inc., Foster City, CA) and recorded on DAT tape using an analog to digital tape recorder (DT-1204; Biologic, Claix, France). Membrane currents were continuously monitored on a digital oscilloscope and a chart recorder. For computer analysis, acetylcholine (ACh)-evoked currents were played back from digital tape, filtered, and digitized (Digidata 1200A; Axon Instruments Inc.). Whole-cell currents were filtered at 1 kHz (-3 dB; 4-pole Bessel filter), sampled at 3 kHz and acquired to a PC Pentium/100 MHz computer using the Axoscope 1.0 and pClamp 6 acquisition programs (Axon Instruments Inc.). Data are expressed as mean Ϯ S.E.
The control external solution for dialyzed and perforated whole-cell recordings was physiological saline solution containing (mM): 140 NaCl, 3 KCl, 2.5 CaCl 2 , 1.2 MgCl 2 , 7.7 glucose, and 10 HEPES-NaOH, pH 7. N-methyl-d-glucamine) . The recording chamber was continuously perfused (2 ml/min) with the indicated solutions at room temperature (22-23°C). ACh-evoked responses were elicited during whole-cell recordings by focal and rapid application of 500 M ACh Ϯ synthetic EpI or [Tyr 15 ]EpI in physiological saline solution containing 100 nM atropine from a multibarrel flow pipe mounted on a piezoelectric positioning system (PZS-200; Burleigh Instruments, Inc., Fishers, NY). Atropine (0.1-1 M) was added to both the bath and solutions through the multibarrel flow pipes to inhibit muscarinic receptor-mediated currents observed in perforated-patch whole-cell recordings (30) . The flow pipe constructed from -tubing was positioned 50 m from the cell soma to evoke maximal responses to ACh. The osmotic activities of the solutions were monitored with a vapor pressure osmometer (Wescor 5500).
Materials for Chromaffin Cell Culture and Parasympathetic Neuron Studies
For chromaffin cells, culture media, penicillin (G, sodium, NF grade), streptomycin sulfate, and fetal calf serum were obtained from Life Technologies, Inc. Collagenase A was from Boehringer-Mannheim and Percoll from Pharmacia. Tissue culture plates were from Sarstedt. Bovine serum albumin was from HÄ MOSAN, perchloric acid and buffer salts were from BDH Chemicals Ltd., and all stock solutions were prepared in Locke's buffer and stored at -20°C. For rat parasympathetic neuron studies, all chemical reagents were analytical grade. ACh, atropine sulfate, and mecamylamine hydrochloride were from Sigma and ␣-bungarotoxin was from Calbiochem (La Jolla, CA).
RESULTS
Isolation and Chemical Characterization of EpI
Identification of EpI-Most ␣-conotoxins identified to date have two disulfide bonds, fall within the mass range 1300 -2000 Da, and elute at relatively low concentrations of organic solvent on reversed-phase chromatography. HPLC/MS ( Fig.  2A) and HPLC (not shown) of a crude extract from C. episcopatus revealed a major, early eluting peak (at 22 or 19 min by analytical or preparative HPLC, respectively) that was identified as a new conopeptide we named EpI. EpI was present in the crude venom at 1-5% of the A 214 absorbing material.
Selected scans from two HPLC/MS runs at different declustering potentials of 15 and 50 V are shown in Fig. 2 , B and C. At the lower declustering potential, two coeluting masses differing by 80 Da were observed, while at higher declustering potentials the lower mass predominated. These spectra, together with the observation of a reduced tendency to lose 80 Da when analyzed in negative ion detection mode (31), suggested EpI was a sulfated peptide of average molecular mass 1866.6 Da. Further confirmation of the presence of a sulfated amino acid being present in EpI was obtained using a high declustering potential (-220 V) and negative ion detection. The resultant mass spectrum revealed the presence of characteristic sulfate ions, SO 3 Ϫ and SO 4 Ϫ at m/z 80 and 96, respectively (data not shown). Comparison of the spectra of EpI to those of CCK-8 (a sulfated peptide) and MLP 111 (a phosphorylated peptide) confirmed that EpI was sulfated (data not shown).
Primary and Secondary Structure of EpI-Purified EpI was reduced, alkylated, and its sequence determined by Edman sequencing to be GCCSDPRCNMNNPDYC. This sequence gave the predicted relative molecular mass (M r ) of 1787. . MS indicated that the carboxyl terminus was amidated, assuming one residue was sulfated (data not shown). MS also showed that residues at positions 2 and 8 had been selectively alkylated and that EpI possessed two disulfide bonds (data not shown).
Identifying the Post-translational Modification-Reduced and alkylated EpI was cleaved with trypsin to generate two fragments which were analyzed by MS and further fragmented by MS/MS to help locate the site of the ϩ80 Da modification. This showed that the modification was in the COOH-terminal fragment, most likely at Tyr 15 (data not shown). EpI was also digested with carboxypeptidase Y to generate an enzymic hydrolysate and, after treatment of the hydrolysate with PITC, amino acid analysis of this material showed that the tyrosine residue was sulfated (Fig. 3) . 15 ]EpI-Solid phase chemical synthesis of EpI was undertaken to confirm the proposed structure of EpI and to provide sufficient material for further biological (present study) and structural characterization. 2 The cleavage conditions selected to remove reduced EpI from resin were a compromise between achieving adequate removal of the side chain protecting groups and preventing undesirable desulfation. Problems were encountered with the incomplete removal of the tBu and Pmc protecting groups. Unfortunately, the use of 1,2-ethanedithiol to scavenge tBu and thioanisole to accelerate Arg(Pmc) deprotection by trifluoroacetic acid is incompatible with sulfopeptide synthesis (33) . Oxidation of pure reduced EpI resulted in the production of one major isomer and two minor isomers. The major oxidized product, which eluted earlier than the reduced form, was purified by reversed-phase HPLC and compared with native EpI. MS results were consistent with the amidated form (synthetic EpI calculated M r 1867.08 Da, observed molecular mass 1866.6 Da). Oxidized synthetic EpI coeluted with the native EpI peptide (Fig. 4) . HPLC chromatograms (Fig. 4) and MS analyses (data not shown) confirmed the 15 ]EpI were tested in the rat phrenic nervehemidiaphragm preparation (26) . Neither peptide significantly inhibited single twitches, train-of-four twitches, or tetanic contractions after incubation for 1 h over the concentration range 1-10 nM (data not shown).
Synthesis of EpI and [Tyr
Mode of Action of EpI Muscle-type Nicotinic Acetylcholine Receptor Response-Synthetic EpI and [Tyr
Neuronal-type Nicotinic Acetylcholine Receptor ResponseSynthetic EpI and [Tyr
15
]EpI inhibited nicotine-induced catecholamine release in bovine chromaffin cells (Fig. 5) . EpI inhibited 50% of nicotine-induced adrenaline and noradrenaline release at 8. ]EpI appear to be full functional antagonists of nicotine-evoked noradrenaline and adrenaline release (Fig.  5A) . K ϩ -induced catecholamine release was not inhibited by either peptide up to 10 M (data not shown), indicating that the inhibition by EpI of nicotine-evoked catecholamine secretion was via inhibition at the nAChRs, rather than by block of the voltage-gated ion channels.
Addition of EpI (1 M) with various concentrations of nicotine (0 -100 M) resulted in a parallel shift of the nicotine doseresponse curve to the right (Fig. 5B) . [Tyr 15 ]EpI caused a similar shift in the nicotine dose-response curve (data not shown). These observations are consistent with EpI and [Tyr 15 ]EpI acting as functional competitive inhibitors of nicotine action at the nAChR.
ACh-evoked Membrane Currents in Rat Parasympathetic Neurons-To further investigate the effects of synthetic EpI on neuronal AChRs, whole-cell recording of membrane currents evoked in response to rapid application of ACh was carried out in isolated parasympathetic neurons from rat intracardiac ganglia. ACh-evoked currents obtained in response to 500 M ACh in a neuron held at -60 mV are shown in Fig. 6 (control traces) .
ACh-evoked peak current amplitude was substantially larger than previously reported in these neurons (27, 30, 34) due to the rapid application of ACh minimizing nicotinic ACh receptor desensitization (35) . ACh-evoked currents were completely and reversibly inhibited by bath application of 1 M mecamylamine. In the presence of 1 nM EpI, the ACh-evoked current amplitude was reversibly decreased by 24% but the kinetics of the response appeared unchanged (Fig. 6A) . The percentage inhibition of ACh-evoked current observed over the voltage range -120 to -20 mV was similar, indicating that the block at the nicotinic AChR was not voltage dependent. Bath application of 300 pM [Tyr 15 ]EpI similarly reduced the amplitude of the AChevoked current by 27% and its effect was reversible upon washout (Fig. 6B ). ]EpI concentrations up to 1 M was 60% of the peak ACh-evoked current. The EpI-resistant current was observed in the majority (Ͼ80%) although not all neurons studied, and was blocked by ␣-bungarotoxin.
DISCUSSION
We have isolated and characterized a new ␣-conotoxin, EpI, from the venom of the molluscivorous snail C. episcopatus collected from the Great Barrier Reef, Australia. The peptide was classified as an ␣-conotoxin based on sequence, disulfide connectivity, and pharmacology. ␣-Conotoxin EpI is the first sulfated conotoxin characterized. The sulfate, which is on Tyr 15 of EpI, is almost completely lost at declustering potentials used routinely for the MS analysis of peptides (Ն40 V), making its detection difficult. However, the sulfotyrosine could be identified by amino acid analysis and MS at low declustering potentials or in negative ion detection mode (31) . The coelution of native and synthetic EpI support our direct evidence that EpI was sulfated at Tyr 15 . Interestingly, no [Tyr 15 ]EpI was detected in the venom of C. episcopatus.
While extensive post-translational modifications are characteristic of conopeptides, phosphorylation or sulfation in conotoxins has not previously been demonstrated. However, the possible presence of sulfated and/or phosphorylated derivatives of PnIB has been suggested on the basis of a mass difference of 80 Da in unconfirmed observations of Fainzilber et al. (36) . Tyrosine sulfation has been recognized as a widespread posttranslational modification of proteins and consensus features of tyrosine sulfation sites have been described (37, 38) . The known tyrosine-sulfated proteins can be classified into discrete functional classes including blood clotting factors, neuropeptides, extracellular matrix proteins, and immune system proteins (37) . A recent revision of the consensus features for tyrosine O-sulfation based on mutational analysis experiments found, contrary to previous findings (i) that neighboring residues contribute only moderately to sulfation and (ii) that extensive sulfation can be obtained despite dramatic changes in the charge distribution of the neighboring residues, with basic residues not only being permissible near the site of sulfation but perhaps enhancing sulfation (39) . The single critical position for tyrosine O-sulfation is Ϫ1, which should contain a neutral or acidic residue. EpI fulfils these requirements. Another suggested consensus feature for tyrosine sulfation is the absence of disulfide-bonded cysteine residues from -7 to ϩ7 (37, 38) . EpI clearly does not fit this criterion, possessing a disulfide-bonded cysteine residue at -7 and ϩ1. However, there is no direct evidence that disulfide bonds necessarily prevent the sulfation of tyrosine (38) . EpI may be the first example of this motif. The functional role of sulfation in this ␣-conotoxin is less clear. Aside from any effect on potency or selectivity, sulfation may have evolved as a strategy to improve the in vivo stability of conotoxins. However, reports in the literature are equivocal. Differential behavior of sulfated and unsulfated peptides has been observed in studies of the degradation of human gastrin and cholecystokinin by endopeptidase, where the presence of a sulfate group reduced the rate of hydrolysis of gastrin by endopeptidase, yet enhanced cholecystokinin degradation by the same enzyme (40) .
EpI is constructed with 4 residues in loop one and 7 residues in loop two and was anticipated to have a structure similar to those reported for PnIA and PnIB (41, 42) . Compared with other 4/7 framework ␣-conotoxins, EpI has homology to both loop one and loop two of PnIA and PnIB and to loop one of MII (see Table I ). The ␣-conotoxins EpI, MII (10, 43, 44) , PnIA, PnIB (36) , and ImI (9, 43, 45) all contain 4 amino acid residues in loop one, the first of which is serine, suggesting that this construct may be important for neuronal nAChR selectivity. The crystal structure of [Tyr 15 ]EpI and a detailed comparison with PnIA and PnIB are reported elsewhere. 2 The activities of synthetic EpI and its unsulfated analogue [Tyr 15 ]EpI were similar. Both caused competitive inhibition of nicotine-induced catecholamine release in bovine adrenal chromaffin cells (predominantly neuronal ␣3␤4 nAChRs (46)) but neither had an effect on the rat phrenic nerve-hemidiaphragm (muscle nAChRs). Thus EpI and [Tyr 15 ]EpI are selective inhibitors of neuronal nAChRs. At nanomolar concentrations, both peptides partially inhibited ACh-evoked currents in a dose-dependent manner in isolated parasympathetic neurons of rat intracardiac ganglia. The EpI block of nAChRs was reversible and did not exhibit any voltage dependence. The residual current that remained after saturating doses of EpI or [Tyr 15 ]EpI was found to be sensitive to inhibition by ␣-bungarotoxin, indicating that EpI has little, if any, effect on neuronal ␣7 nAChRs of rats. Given that the remainder of the ACh-evoked current in rat parasympathetic neurons arises from nAChRs constructed primarily of ␣3␤2 and/or ␣3␤4 subunits (47), it appears that EpI selectively inhibits neuronal ␣3␤2 and ␣3␤4 nAChRs. The difference in the rank order of potency between EpI and [Tyr 15 ]EpI at bovine chromaffin cells and rat parasympathetic neurons may indicate that sulfation has an effect on selectivity across rat and bovine nAChRs. It is possible that EpI may have evolved to selectively target molluscan forms of the nAChR as part of the prey capture strategy of C. episcopatus. The more than 50-fold difference in absolute potency between EpI and [Tyr 15 ]EpI at bovine chromaffin cells and rat (43) . Species differences in the susceptibility of muscle-and neuronal-nicotinic receptors to ␣-conotoxins have also been noted for ␣-conotoxins MI (44) and ImI (9) .
With respect to its ability to inhibit nAChRs in bovine chromaffin cells, EpI is the most potent of the ␣-conotoxins tested to date, being 5-fold more potent than PnIB (IC 50 ϭ 0.7 M) and 20-fold more potent than ImI (IC 50 ϭ 3 M) (43) . It is unlikely that EpI targets bovine ␣7 receptors, given that EpI inhibits both adrenaline and noradrenaline secretion in bovine chromaffin cells but only the adrenaline cells contain ␣7 (49). Furthermore, studies in the rat parasympathetic intracardiac ganglia indicate that EpI has little if any effect on rat neuronal ␣7 nAChRs. It has previously been shown that ␣-conotoxin MII specifically targets rat ␣3␤2 nAChRs (10, 44), whereas we show here that EpI and [Tyr 15 ]EpI likely target rat ␣3␤2 and ␣3␤4. On the basis that Campos-Caro et al. (46) have shown that there is no ␤2 subunit expressed in bovine chromaffin cells (which contain neuronal ␣3, ␣5, ␣7, and ␤4 subunits) it appears that EpI targets bovine ␣3␤4 receptors. However, there is pharmacological evidence that ␣3␤4 in bovine chromaffin cells behaves similarly to ␣3␤2 in the rat (46, 50) .
Our findings with EpI reinforce those of Groebe et al. (48) with MI who suggest that caution should be exercised when ␣-conotoxins are used to pharmacologically define the nicotinic receptor subtypes across different species. A radioligand binding assay utilizing [ 125 I-Tyr 15 ]EpI to more precisely define its site of binding in different species is under development. The recent finding of Kulak et al. (14) shows that ␣-conotoxins with appropriate nAChR-subtype specificity have potential as novel therapeutics. Given that its structure is now well defined, 2 EpI provides a useful template for the design of selective small molecule inhibitors of neuronal nAChRs.
FIG. 6. Synthetic EpI and [Tyr
15
]EpI inhibition of nicotinic ACh-evoked currents in parasympathetic neurons from rat intracardiac ganglia. A, superimposed traces of whole-cell currents evoked in response to rapid application of 500 M ACh in the absence (Control) and presence of 1 nM EpI (E). AChevoked currents were obtained at a holding potential of -60 mV under perforated patch whole-cell recording conditions at 22°C. B, superimposed traces of whole-cell ACh-evoked currents in a neuron held at -60 mV in the absence and presence of 300 pM [Tyr 15 ]EpI (q). C, superimposed traces of ACh-evoked currents obtained from a dialyzed neuron held at -60 mV in the absence (Control) and presence of 300 nM EpI (E) or 300 nM [Tyr 15 ]EpI (q). D, dose-dependent inhibition of ACh-evoked peak current by EpI (E) and [Tyr 15 ]EpI (q) normalized to the peak current amplitude of the AChevoked current obtained at -60 mV in the absence of EpI. The dose-response relations were fit with a single site adsorption isotherm giving IC 50 
